88 related articles for article (PubMed ID: 18050205)
1. Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus.
Zhang L; Bertucci AM; Smith KA; Xu L; Datta SK
Arthritis Rheum; 2007 Dec; 56(12):4132-41. PubMed ID: 18050205
[TBL] [Abstract][Full Text] [Related]
2. Prolonged low-dose administration of the cyclooxygenase-2 inhibitor celecoxib enhances the antitumor activity of irinotecan against neuroblastoma xenografts.
Kaneko M; Kaneko S; Suzuki K
Cancer Sci; 2009 Nov; 100(11):2193-201. PubMed ID: 19673886
[TBL] [Abstract][Full Text] [Related]
3. The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models.
Katewa A; Suto E; Hui J; Heredia J; Liang J; Hackney J; Anderson K; Alcantar TM; Bacarro N; Dunlap D; Eastham J; Paler-Martinez A; Rairdan XY; Modrusan Z; Lee WP; Austin CD; Lafkas D; Ghilardi N
PLoS One; 2021; 16(1):e0244439. PubMed ID: 33444326
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cells.
Ryan EP; Bushnell TP; Friedman AE; Rahman I; Phipps RP
Cancer Immunol Immunother; 2008 Mar; 57(3):347-58. PubMed ID: 17668203
[TBL] [Abstract][Full Text] [Related]
5. Dual Role of Interleukin-10 in Murine NZB/W F1 Lupus.
Amend A; Wickli N; Schäfer AL; Sprenger DTL; Manz RA; Voll RE; Chevalier N
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572870
[TBL] [Abstract][Full Text] [Related]
6. COX-2 overexpression increases malignant potential of human glioma cells through Id1.
Xu K; Wang L; Shu HK
Oncotarget; 2014 Mar; 5(5):1241-52. PubMed ID: 24659686
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 inhibition prevents renal toxicity but not hypertension during sunitinib treatment.
van Dorst DCH; Mirabito Colafella KM; van Veghel R; Garrelds IM; de Vries R; Mathijssen RHJ; Danser AHJ; Versmissen J
Eur J Pharmacol; 2024 Jan; 962():176199. PubMed ID: 38029870
[TBL] [Abstract][Full Text] [Related]
8. Repurposed Drugs Celecoxib and Fmoc-L-Leucine Alone and in Combination as Temozolomide-Resistant Antiglioma Agents-Comparative Studies on Normal and Immortalized Cell Lines, and on
Uram Ł; Pieńkowska N; Misiorek M; Szymaszek Ż; Twardowska M; Siorek M; Wołowiec S
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542198
[TBL] [Abstract][Full Text] [Related]
9. Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasis.
Zhang Y; Du L; Wang C; Jiang Z; Duan Q; Li Y; Xie Z; He Z; Sun Y; Huang L; Lu L; Wen C
Signal Transduct Target Ther; 2024 Jan; 9(1):18. PubMed ID: 38221551
[TBL] [Abstract][Full Text] [Related]
10. Epinephrine promotes COX-2-dependent immune suppression in myeloid cells and cancer tissues.
Muthuswamy R; Okada NJ; Jenkins FJ; McGuire K; McAuliffe PF; Zeh HJ; Bartlett DL; Wallace C; Watkins S; Henning JD; Bovbjerg DH; Kalinski P
Brain Behav Immun; 2017 May; 62():78-86. PubMed ID: 28212885
[TBL] [Abstract][Full Text] [Related]
11. Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise.
Bernard MP; Bancos S; Sime PJ; Phipps RP
Curr Pharm Des; 2008; 14(21):2051-60. PubMed ID: 18691115
[TBL] [Abstract][Full Text] [Related]
12. COX 2-inhibitors; a thorough and updated survey into combinational therapies in cancers.
Rodrigues P; Bangali H; Hammoud A; Mustafa YF; Al-Hetty HRAK; Alkhafaji AT; Deorari MM; Al-Taee MM; Zabibah RS; Alsalamy A
Med Oncol; 2024 Jan; 41(1):41. PubMed ID: 38165473
[TBL] [Abstract][Full Text] [Related]
13. L-arginine supplementation protects against thrombosis and renal dysfunction in mice treated with the cyclooxygenase-2 inhibitor parecoxib.
Vaja R; Lopes-Pires M; Shala F; Cypaite N; Vinokurova M; Ferreira P; Mitchell JA; Kirkby NS
J Thromb Haemost; 2024 Jun; 22(6):1798-1801. PubMed ID: 38518895
[No Abstract] [Full Text] [Related]
14. Aspirin Attenuates Cardiac Allograft Rejection by Inhibiting the Maturation of Dendritic Cells
Zhang X; Chang A; Zou Y; Xu H; Cui J; Chen Z; Li Y; Du Y; Wu J; Yu J; Du X
Front Pharmacol; 2021; 12():706748. PubMed ID: 34483913
[No Abstract] [Full Text] [Related]
15. Oxidative Stress and Lipid Mediators Modulate Immune Cell Functions in Autoimmune Diseases.
Wójcik P; Gęgotek A; Žarković N; Skrzydlewska E
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450863
[TBL] [Abstract][Full Text] [Related]
16. Black pepper and its bioactive constituent piperine: promising therapeutic strategies for oral lichen planus.
Yang JY; Zhang J; Zhou G
Inflammopharmacology; 2019 Feb; 27(1):5-13. PubMed ID: 30343451
[TBL] [Abstract][Full Text] [Related]
17. Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway.
Hu Q; Yang C; Wang Q; Zeng H; Qin W
PLoS One; 2015; 10(7):e0133724. PubMed ID: 26208003
[TBL] [Abstract][Full Text] [Related]
18. Viscum album-mediated COX-2 inhibition implicates destabilization of COX-2 mRNA.
Saha C; Hegde P; Friboulet A; Bayry J; Kaveri SV
PLoS One; 2015; 10(2):e0114965. PubMed ID: 25664986
[TBL] [Abstract][Full Text] [Related]
19. Human parvovirus B19 NS1 protein aggravates liver injury in NZB/W F1 mice.
Tsai CC; Chiu CC; Hsu JD; Hsu HS; Tzang BS; Hsu TC
PLoS One; 2013; 8(3):e59724. PubMed ID: 23555760
[TBL] [Abstract][Full Text] [Related]
20. The beneficial role of vitamin D in systemic lupus erythematosus (SLE).
vinh quốc Luong K; Nguyễn LT
Clin Rheumatol; 2012 Oct; 31(10):1423-35. PubMed ID: 22801788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
